BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36544170)

  • 1. LncRNA EBLN3P attributes methotrexate resistance in osteosarcoma cells through miR-200a-3p/O-GlcNAc transferase pathway.
    Sun MX; An HY; Sun YB; Sun YB; Bai B
    J Orthop Surg Res; 2022 Dec; 17(1):557. PubMed ID: 36544170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA EBLN3P promotes the progression of osteosarcoma through modifying the miR-224-5p/Rab10 signaling axis.
    Dai S; Li N; Zhou M; Yuan Y; Yue D; Li T; Zhang X
    Sci Rep; 2021 Jan; 11(1):1992. PubMed ID: 33479458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ_0081001 knockdown enhances methotrexate sensitivity in osteosarcoma cells by regulating miR-494-3p/TGM2 axis.
    Wei W; Ji L; Duan W; Zhu J
    J Orthop Surg Res; 2021 Jan; 16(1):50. PubMed ID: 33435987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA endogenous bornavirus-like nucleoprotein acts as an oncogene by regulating microRNA-655-3p expression in T-cell acute lymphoblastic leukemia.
    Yang J; Yang Y
    Bioengineered; 2022 Mar; 13(3):6409-6419. PubMed ID: 35220878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA HCG9 Promotes Osteosarcoma Progression through RAD51 by Acting as a ceRNA of miR-34b-3p.
    Wang L; Li S; Qi L; Ling L
    Mediators Inflamm; 2021; 2021():9978882. PubMed ID: 34456631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0000073 contributes to osteosarcoma cell proliferation, migration, invasion and methotrexate resistance by sponging miR-145-5p and miR-151-3p and upregulating NRAS.
    Li X; Liu Y; Zhang X; Shen J; Xu R; Liu Y; Yu X
    Aging (Albany NY); 2020 Jul; 12(14):14157-14173. PubMed ID: 32706759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma.
    Xu W; Li Z; Zhu X; Xu R; Xu Y
    Med Sci Monit; 2018 Dec; 24():8812-8821. PubMed ID: 30518744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma.
    Xu R; Feng F; Yu X; Liu Z; Lao L
    Cell Prolif; 2018 Dec; 51(6):e12515. PubMed ID: 30152090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
    Han Z; Shi L
    Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA ODRUL regulates progression of osteosarcoma by regulating IL-6 via sponging miR-6874-3p.
    Zhan T; Zhu K; Hu J; Ma X; Zhu Y; Zhang C
    Exp Cell Res; 2022 Mar; 412(2):113050. PubMed ID: 35114192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis.
    Zhou Y; Yin L; Li H; Liu LH; Xiao T
    Cancer Biol Ther; 2019; 20(8):1141-1148. PubMed ID: 30975024
    [No Abstract]   [Full Text] [Related]  

  • 16. LncRNA DLEU2 promotes tumour growth by sponging miR-337-3p in human osteosarcoma.
    Liu W; Liu PC; Ma K; Wang YY; Chi QB; Yan M
    Cell Biochem Funct; 2020 Oct; 38(7):886-894. PubMed ID: 32196715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells.
    Bazavar M; Fazli J; Valizadeh A; Ma B; Mohammadi E; Asemi Z; Alemi F; Maleki M; Xing S; Yousefi B
    Pathol Res Pract; 2020 Nov; 216(11):153176. PubMed ID: 32861171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HULC induces the progression of osteosarcoma by regulating the miR-372-3p/HMGB1 signalling axis.
    Li Y; Liu JJ; Zhou JH; Chen R; Cen CQ
    Mol Med; 2020 Mar; 26(1):26. PubMed ID: 32188407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.
    Dai J; Lu L; Kang L; Zhang J
    Hum Cell; 2021 Mar; 34(2):624-633. PubMed ID: 33415690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
    Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
    Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.